Ataxia-Telangiectasia Group D Complementing Gene (ATDC) Promotes Lung Cancer Cell Proliferation by Activating NF-κB Pathway

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Tang, Zhong Ping ^a   Dong, Qian Ze ^a   Cui, Quan Zhe ^a   Papavassiliou, Paulie ^b   Wang, En Di ^b   Wang, En Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CYCLIN D1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PROTEIN P53; SMALL INTERFERING RNA; WNT PROTEIN;

ADULT; ARTICLE; ATAXIA TELANGIECTASIA GROUP D COMPLEMENTING GENE; BRONCHUS MUCOSA; CANCER CELL; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHINA; CYCLIN D1; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR STEM CELL ASSAY;

ATAXIA TELANGIECTASIA;

EID: 84878943571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063676     Document Type: Article

References (49)

1. Minna JD, Roth JA, Gazdar AF, (2002) Focus on lung cancer. Cancer Cell 1: 49-52.
2. Jemal A, Siegel R, Xu J, Ward E Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
3. Poste G, Fidler IJ, (1980) The pathogenesis of cancer metastasis. Nature 283: 139-146.
4. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al. (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98.
5. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. (2001) The tripartite motif family identifies cell compartments. EMBO J 20: 2140-2151.
6. Zhao G, Ke D, Vu T, Ahn J, Shah VB,et al. Rhesus TRIM5alpha disrupts the HIV-1 capsid at the inter-hexamer interfaces. PLoS Pathog 7: e1002009.
7. Oliveira NM, Trikha R, McKnight A A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5alpha independent. Retrovirology 7: 81.
8. Li Q, Yan J, Mao AP, Li C, Ran Y,et al. Tripartite motif 8 (TRIM8) modulates TNFalpha- and IL-1beta-triggered NF-kappaB activation by targeting TAK1 for K63-linked polyubiquitination. Proc Natl Acad Sci U S A 108: 19341-19346.
9. Liu XL, Lei XB, Wang JW, Hong T [Identification A novel protein TRIM38 that activate NF-kappaB signaling pathways]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 25: 60-62.
10. Yu S, Gao B, Duan Z, Xu W, Xiong S Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-kappaB activator. Biochem Biophys Res Commun 410: 247-251.
11. Noguchi K, Okumura F, Takahashi N, Kataoka A, Kamiyama T,et al. TRIM40 promotes neddylation of IKKgamma and is downregulated in gastrointestinal cancers. Carcinogenesis 32: 995-1004.
12. Kapp LN, Painter RB, Yu LC, van Loon N, Richard CW, 3rd, et al (1992) Cloning of a candidate gene for ataxia-telangiectasia group D. Am J Hum Genet. 51: 45-54.
13. Wang L, Heidt DG, Lee CJ, Yang H, Logsdon CD, et al. (2009) Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell 15: 207-219.
14. Hawthorn L, Stein L, Panzarella J, Loewen GM, Baumann H, (2006) Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung. Lung Cancer 53: 129-142.
15. Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, et al. (2007) Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol 14: 2543-2549.
16. Dyrskjot L, Kruhoffer M, Thykjaer T, Marcussen N, Jensen JL, et al. (2004) Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64: 4040-4048.
17. Glebov OK, Rodriguez LM, Soballe P, DeNobile J, Cliatt J, et al. (2006) Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa. Cancer Epidemiol Biomarkers Prev 15: 2253-2262.
18. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, et al. (2006) Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12: 3057-3063.
19. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, et al. (2004) Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 112: 14-25.
20. Mutter GL, Baak JP, Fitzgerald JT, Gray R, Neuberg D, et al. (2001) Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol 83: 177-185.
21. Zhan F, Hardin J, Kordsmeier B, Bumm K, Zheng M, et al. (2002) Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99: 1745-1757.
22. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, et al. (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22: 2790-2799.
23. Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, et al. (2001) Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 61: 4683-4688.
24. LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, et al. (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 62: 4499-4506.
25. Zhang P, Zhang Z, Zhou X, Qiu W, Chen F, et al. (2006) Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer 6: 224.
26. Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, et al. (1999) Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res 59: 5464-5470.
27. Smith AP, Hoek K, Becker D, (2005) Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol Ther 4: 1018-1029.
28. Yuan Z, Villagra A, Peng L, Coppola D, Glozak M,et al. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol 30: 3004-3015.
29. Brzoska PM, Chen H, Zhu Y, Levin NA, Disatnik MH, et al. (1995) The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc Natl Acad Sci U S A 92: 7824-7828.
30. Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, et al. (2005) Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res 11: 232-241.
31. Li YJ, Wei ZM, Meng YX, Ji XR, (2005) Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol 11: 2117-2123.
32. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES, (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620-1628.
33. Ratschiller D, Heighway J, Gugger M, Kappeler A, Pirnia F, et al. (2003) Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol 21: 2085-2093.
34. Roy PG, Thompson AM, (2006) Cyclin D1 and breast cancer. Breast 15: 718-727.
35. Keum JS, Kong G, Yang SC, Shin DH, Park SS, et al. (1999) Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer 81: 127-132.
36. Karn J, Watson JV, Lowe AD, Green SM, Vedeckis W, (1989) Regulation of cell cycle duration by c-myc levels. Oncogene 4: 773-787.
37. Shichiri M, Hanson KD, Sedivy JM, (1993) Effects of c-myc expression on proliferation, quiescence, and the G0 to G1 transition in nontransformed cells. Cell Growth Differ 4: 93-104.
38. Ames BN, Gold LS, (1998) The causes and prevention of cancer: the role of environment. Biotherapy 11: 205-220.
39. Yuan Z, Peng L, Radhakrishnan R, Seto E Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein. J Biol Chem 285: 39329-39338.
40. Sho T, Tsukiyama T, Sato T, Kondo T, Cheng J,et al. TRIM29 negatively regulates p53 via inhibition of Tip60. Biochim Biophys Acta 1813: 1245-1253.
41. Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H, (2007) Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer. Mol Carcinog 46: 807-817.
42. Tung JN, Chiang CC, Tsai YY, Chou YY, Yeh KT,et al. CyclinD1 protein expressed in pterygia is associated with beta-catenin protein localization. Mol Vis 16: 2733-2738.
43. Abbas T, Dutta A, (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414.
44. Baldwin AS, (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107: 241-246.
45. Chen C, Edelstein LC, Gelinas C, (2000) The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20: 2687-2695.
46. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr, (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799.
47. Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, et al. (2007) Inactivation of NF-kappaB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol Cancer Ther 6: 2757-2765.
48. Tew GW, Lorimer EL, Berg TJ, Zhi H, Li R, et al. (2008) SmgGDS regulates cell proliferation, migration, and NF-kappaB transcriptional activity in non-small cell lung carcinoma. J Biol Chem 283: 963-976.
49. Fernandez-Majada V, Aguilera C, Villanueva A, Vilardell F, Robert-Moreno A, et al. (2007) Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci U S A 104: 276-281.